| ¿µ¹® | albumin | ÇÑ±Û | ¾ËºÎ¹Î |
|---|---|---|---|
| ¼³¸í | 1.¹°¿¡ ³ìÀ» ¼ö ÀÖ°í ³ìÀº ÈÄ¿¡ ¿À» °¡ÇÏ¸é º¯¼ºÀ» ÀÏÀ¸Å°´Â ¸ðµç ´Ü¹éÁúÀÇ ÃÑĪ. 2.Ç÷û ¾ËºÎ¹ÎÀÇ Àǹ̷Π¾²ÀδÙ. Ç÷ûÀ̶õ ÇǸ¦ »Ì¾Æ ¹æÄ¡ÇßÀ» °æ¿ì¿¡ Ç÷¾×ÀÀ°í°¡ µÇ°í ³ µÚ¿¡ ³²¾ÆÀÖ´Â ¸¼Àº ¾×À» ¸»ÇÏ´Â µ¥ À̰÷¿¡ ³ì¾ÆÀÖ´Â »ç¶÷ÀÇ ´Ü¹éÁúÀ» Ç÷û ´Ü¹éÁúÀ̶ó°í Çϰí ÀÌ Ç÷û´Ü¹éÁúÀÇ ´ëºÎºÐ(60%)À» Â÷ÁöÇÏ´Â °ÍÀÌ ¾ËºÎ¹ÎÀÌ´Ù. ÀÌ ¾ËºÎ¹ÎÀÇ ±â´ÉÀº ¿ì¼± Ç÷¾×¼Ó¿¡ ÀÖ´Â ¿©·¯ °¡Áö È£¸£¸ó µîÀÇ ¹°Áú°ú °áÇÕÇÏ¿© ±× ¹°ÁúÀÇ ºÐÇØ¸¦ ¸·°í ´Ù¸¥ °÷À¸·Î À̵¿½ÃŰ´Â ¿ªÇÒ°ú Ç÷¾×ÀÇ »ïÅõ¾ÐÀ» À¯ÁöÇÏ´Â ÀÏÀ» ÇÑ´Ù. |
||
| ¿µ¹® | serum | ÇÑ±Û | Ç÷û |
|---|---|---|---|
| ¼³¸í | Ç÷¾×ÀÇ ¼ººÐ Áß °íÇü¼ººÐÀÎ Ç÷±¸¼¼Æ÷(ÀûÇ÷±¸, ¹éÇ÷±¸ µî), Ç÷¼ÒÆÇÀ» Á¦¿ÜÇÑ ºÎºÐÀ» Ç÷ÀåÀ̶ó°í Çϰí, Ç÷Àå¿¡¼ ¼¶À¯¼Ò¸¦ Á¦¿ÜÇÑ ºÎºÐÀ» Ç÷ûÀ̶ó°í ÇÑ´Ù. |
||
| ¿µ¹® | serum proteins | ÇÑ±Û | Ç÷û´Ü¹é |
|---|---|---|---|
| ¼³¸í | Ç÷û¿¡ ÀÖ´Â ´Ü¹éÁúµéÀ» ÃÑĪÇÏ´Â ¸»·Î, ¸é¿ª±Û·ÎºÒ¸°(¸é¿ªÇö»ó¿¡ °ü¿©ÇÏ´Â Ç×ü¸¦ Çü¼ºÇÔ), ¾ËºÎ¹Î, º¸Ã¼ ¹× ÀÀ°íÀÎÀÚ¿Í ¿©·¯ È¿¼ÒµéÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù. |
||
| ¿µ¹® | serum enzyme | ÇÑ±Û | Ç÷ûȿ¼Ò |
|---|---|---|---|
| ¼³¸í | Ç÷û ³»¿¡ Æ÷ÇԵǾî ÀÖ´Â ¿©·¯ °¡Áö È¿¼Ò¸¦ ÀÏÄ´ ¸»ÀÌ´Ù. |
||
| HSA | Hazardous Substances Act; Health Services Administration; health systems agency; hereditary siderobl... |
|---|---|
| A/G ratio | Albumin/Globulin ratio; ¾ËºÎ¹Î´ë ±Û·ÎºÒ¸°ÀÇ ºñÀ² |
| SA | salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame... |
| AR | absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista... |
| L/S | lactase/sucrase [ratio]; lecithin/ sphingomyelin [ratio]; lipid/saccharide [ratio]; longitudinal sec... |
| CSF-1 R | CSF-1 receptor |
|---|---|
| G-CSF-R | G-CSF receptor |
| GM-CSF-R | GM-CSF receptor |
| G-CSF | Granulocyte CSF |
| GM-CSF | Granulocyte-macrophage CSF |
CSF
| albumin-globulin ratio | The ratio of albumin to globulin in the serum or in the urine in kidney disease; the normal ratio in the serum is approximately 1.55. (05 Mar 2000) |
|---|---|
| bovine serum albumin | A source of albumin commonly used in in vitro biological studies. (05 Mar 2000) |
| radioiodinated serum albumin | A sterile, buffered, isotonic solution prepared to contain not less than 10 mg of radioiodinated normal human serum albumin per ml, and adjusted to provide not more than 1 mCi of radioactivity per ml; used as a diagnostic aid in determining blood volume and cardiac output. Synonym: radioiodinated serum albumin. (05 Mar 2000) |
| serum albumin | <protein> The serum level of the low molecular protein albumin. Albumin, produced by the liver, plays an important role in maintaining plasma oncotic pressure. Normal serum albumin should be 3.5-5.0 grams per decilitre. Low serum albumin can be found in cases of liver disease and malnutrition. (27 Sep 1997) |
| serum albumin, bovine | Serum albumin from cows, commonly used in in vitro biological studies. (12 Dec 1998) |
| serum albumin, radio-iodinated | <chemical> Normal human serum albumin mildly iodinated with radioactive iodine (131-I) which has a half-life of 8 days, and emits beta and gamma rays. It is used as a diagnostic aid in blood volume determination. Pharmacological action: radiopharmaceuticals. (12 Dec 1998) |
| normal human serum albumin | A sterile preparation of serum albumin obtained by fractionating blood plasma proteins from healthy persons; used as a transfusion material and to treat oedema due to hypoproteinaemia. Synonym: dried human albumin. (05 Mar 2000) |
| iodinated 125I serum albumin | A sterile, buffered, isotonic solution prepared to contain not less than 10 mg of radioiodinated normal human serum albumin per ml, and adjusted to provide not more than 1 mCi of radioactivity per ml; used as a diagnostic aid in determining blood volume and cardiac output. Synonym: radioiodinated serum albumin. (05 Mar 2000) |
| iodinated 131I human serum albumin | A sterile, buffered, isotonic solution prepared to contain not less than 10 mg of radioiodinated normal human serum albumin per ml, and adjusted to provide not more than 1 mCi of radioactivity per ml; used as a diagnostic aid in the measurement of blood volume and cardiac output. (05 Mar 2000) |
| G-CSF | <growth factor, haematology, oncology> A glycoprotein of 25 kD containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukaemic myeloid cell lines. A protein that stimulates the growth and maturation of granulocytes. It is used to promote the recovery of the white cells following chemotherapy. See: colony-stimulating factor. Acronym: G-CSF (12 Dec 1998) |
| M-CSF | macrophage-colony-stimulating factor |
| GM-CSF | <growth factor, haematology, oncology> An acidic glycoprotein of mw 23 kD with internal disulfide bonds. It is produced in response to a number of inflammatory mediators by mesenchymal cells present in the haemopoietic environment and at peripheral sites of inflammation. It stimulates the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from foetal liver progenitor cells. It also has some functional activities in mature granulocytes and macrophages. It is used to promote the recovery of the white blood cells following chemotherapy. Chemical name: Colony-stimulating factor 2 See: colony-stimulating factor. Acronym: GM-CSF (12 Dec 1998) |
| multi-CSF | <abbreviation> Multi-colony-stimulating factor. (05 Mar 2000) |
| CSF | 1. Colony-stimulating factor. 2. Cerebrospinal fluid. (06 Aug 1998) |
| CSF leak | <neurology> The leak of cerebrospinal fluid from the cavities within the brain (ventricles) or the spinal cord. CSF leak is a recognised complication of lumbar puncture. CSF leaks may also be seen after trauma to the head (for example CSF rhinorrhoea, CSF otorrhoea). (06 Aug 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|